These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 2290957)
1. Improvements in MPTP-induced object retrieval deficits and behavioral deficits after fetal nigral grafting in monkeys. Taylor JR; Elsworth JD; Roth RH; Collier TJ; Sladek JR; Redmond DE Prog Brain Res; 1990; 82():543-59. PubMed ID: 2290957 [TBL] [Abstract][Full Text] [Related]
2. Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controls. Taylor JR; Elsworth JD; Roth RH; Sladek JR; Collier TJ; Redmond DE Exp Brain Res; 1991; 85(2):335-48. PubMed ID: 1893983 [TBL] [Abstract][Full Text] [Related]
3. Early gestational mesencephalon grafts, but not later gestational mesencephalon, cerebellum or sham grafts, increase dopamine in caudate nucleus of MPTP-treated monkeys. Elsworth JD; Sladek JR; Taylor JR; Collier TJ; Redmond DE; Roth RH Neuroscience; 1996 May; 72(2):477-84. PubMed ID: 8737417 [TBL] [Abstract][Full Text] [Related]
4. Sham surgery does not ameliorate MPTP-induced behavioral deficits in monkeys. Taylor JR; Elsworth JD; Sladek JR; Collier TJ; Roth RH; Redmond DE Cell Transplant; 1995; 4(1):13-26. PubMed ID: 7728327 [TBL] [Abstract][Full Text] [Related]
5. Restoration of dopamine transporter density in the striatum of fetal ventral mesencephalon-grafted, but not sham-grafted, MPTP-treated parkinsonian monkeys. Elsworth JD; Brittan MS; Taylor JR; Sladek JR; al-Tikriti MS; Zea-Ponce Y; Innis RB; Redmond DE; Roth RH Cell Transplant; 1996; 5(2):315-25. PubMed ID: 8689042 [TBL] [Abstract][Full Text] [Related]
7. Parkinsonian monkeys with prior levodopa-induced dyskinesias followed by fetal dopamine precursor grafts do not display graft-induced dyskinesias. Kordower JH; Vinuela A; Chu Y; Isacson O; Redmond DE J Comp Neurol; 2017 Feb; 525(3):498-512. PubMed ID: 27418401 [TBL] [Abstract][Full Text] [Related]
8. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease. Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337 [TBL] [Abstract][Full Text] [Related]
9. Restoration of complex sensorimotor behavior and skilled forelimb use by a modified nigral cell suspension transplantation approach in the rat Parkinson model. Nikkhah G; Duan WM; Knappe U; Jödicke A; Björklund A Neuroscience; 1993 Sep; 56(1):33-43. PubMed ID: 8232915 [TBL] [Abstract][Full Text] [Related]
10. Upregulation of striatal D2 receptors in the MPTP-treated vervet monkey is reversed by grafts of fetal ventral mesencephalon: an autoradiographic study. Elsworth JD; Brittan MS; Taylor JR; Sladek JR; Redmond DE; Innis RB; Zea-Ponce Y; Roth RH Brain Res; 1998 Jun; 795(1-2):55-62. PubMed ID: 9622593 [TBL] [Abstract][Full Text] [Related]
11. Behavioral recovery from MPTP-induced parkinsonism in monkeys after intracerebral tissue implants is not related to CSF concentrations of dopamine metabolites. Bankiewicz KS; Plunkett RJ; Mefford I; Kopin IJ; Oldfield EH Prog Brain Res; 1990; 82():561-71. PubMed ID: 1705356 [No Abstract] [Full Text] [Related]
16. Behavioral assessment of the effects of embryonic nigral grafts in marmosets with unilateral 6-OHDA lesions of the nigrostriatal pathway. Annett LE; Martel FL; Rogers DC; Ridley RM; Baker HF; Dunnett SB Exp Neurol; 1994 Feb; 125(2):228-46. PubMed ID: 7906227 [TBL] [Abstract][Full Text] [Related]
17. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum. Cenci MA; Kalén P; Mandel RJ; Wictorin K; Björklund A Neuroscience; 1992; 46(4):943-57. PubMed ID: 1347413 [TBL] [Abstract][Full Text] [Related]
18. GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys. Gerhardt GA; Cass WA; Huettl P; Brock S; Zhang Z; Gash DM Brain Res; 1999 Jan; 817(1-2):163-71. PubMed ID: 9889359 [TBL] [Abstract][Full Text] [Related]
19. Long-term survival of grafted cells, dopamine synthesis/release, synaptic connections, and functional recovery after transplantation of fetal nigral cells in rats with unilateral 6-OHDA lesions in the nigrostriatal dopamine pathway. Nishino H; Hashitani T; Kumazaki M; Sato H; Furuyama F; Isobe Y; Watari N; Kanai M; Shiosaka S Brain Res; 1990 Nov; 534(1-2):83-93. PubMed ID: 1981488 [TBL] [Abstract][Full Text] [Related]
20. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--III. Reversal by embryonic nigral dopamine grafts. Sirinathsinghji DJ; Dunnett SB; Northrop AJ; Morris BJ Neuroscience; 1990; 37(3):757-66. PubMed ID: 2247221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]